PBM

Johnson and Johnson is being sued for their role in fiduciary responsibility related to self-funded employers and the management of their pharmacy benefits program.

Proposed Class Action Lawsuit Against Johnson & Johnson Signals Growing Importance of Pharmacy Benefit Oversight for Self-Funded Employer Groups

On February 5, 2024, a class action complaint was filed against one of the nation’s largest self-funded employers, Johnson & Johnson (J&J). In the case, Lewandoski v. Johnson & Johnson, the proposed class is claiming that J&J failed to uphold their fiduciary duty of prudence under ERISA.

Proposed Class Action Lawsuit Against Johnson & Johnson Signals Growing Importance of Pharmacy Benefit Oversight for Self-Funded Employer Groups Read More »

Payer Perspectives on PBM Satisfaction Signal Greater Need for Trust and Accountability in Pharmacy

In 2023, the pharmacy benefit management (PBM) industry witnessed a significant shift in client sentiment. Health plans, employers, health systems and unions reported a notable decrease in satisfaction with their PBM vendors, as detailed in the 2023 Pharmacy Benefit Manager Customer Satisfaction Report by Pharmaceutical Strategies Group (PSG).

Payer Perspectives on PBM Satisfaction Signal Greater Need for Trust and Accountability in Pharmacy Read More »

Are PBM Audits Enough? Examining the Effectiveness of Health Plan Pharmacy Benefit Audits

In this article, HealthPlan Data Solutions’ (HDS) claims analysts will review the purpose and limitations of traditional PBM audits, offer insights to help health plans establish robust pharmacy payment integrity programs, and provide suggestions to enhance accountability in the pharmacy benefit.

Are PBM Audits Enough? Examining the Effectiveness of Health Plan Pharmacy Benefit Audits Read More »

Scroll to Top